Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma.

Di Fiore F, Lecleire S, Rigal O, Galais MP, Ben Soussan E, David I, Paillot B, Jacob JH, Michel P.

World J Gastroenterol. 2006 Jul 14;12(26):4185-90.

2.

Response to definitive chemoradiotherapy and survival in patients with an oesophageal adenocarcinoma versus squamous cell carcinoma: a matched-pair analysis.

Tougeron D, Di Fiore F, Hamidou H, Rigal O, Paillot B, Michel P.

Oncology. 2007;73(5-6):328-34. doi: 10.1159/000134476. Epub 2008 May 23.

PMID:
18497505
3.

VEGF -634C/G genotype is predictive of long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.

Tamura T, Kuwahara A, Yamamori M, Nishiguchi K, Nakamura T, Okuno T, Miki I, Manabe Y, Sakaeda T.

Int J Med Sci. 2012;9(10):833-7. doi: 10.7150/ijms.4914. Epub 2012 Nov 1.

4.

Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy.

Valencia Julve J, Alonso Orduña V, Escó Barón R, López-Mata M, Méndez Villamón A.

Clin Transl Oncol. 2006 Jan;8(1):22-30.

PMID:
16632436
5.

Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.

Murakami M, Kuroda Y, Okamoto Y, Kono K, Yoden E, Kusumi F, Hajiro K, Matsusue S, Takeda H.

Int J Radiat Oncol Biol Phys. 1998 Mar 15;40(5):1049-59.

PMID:
9539559
6.

Impact of radiation schedule and chemotherapy duration in definitive chemoradiotherapy regimen for esophageal cancer.

Di Fiore F, Lecleire S, Galais MP, Rigal O, Vié B, David I, Hamidou H, Paillot B, Jacob JH, Michel P.

Gastroenterol Clin Biol. 2006 Jun-Jul;30(6-7):845-51.

7.

Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers.

Fujita H, Sueyoshi S, Tanaka T, Tanaka Y, Sasahara H, Shirouzu K, Suzuki G, Hayabuchi N, Inutsuka H.

J Surg Oncol. 2005 Jun 15;90(4):209-19.

PMID:
15906363
8.

Endoscopic response predicts for survival and organ preservation after primary chemoradiotherapy for esophageal cancer.

Lim JT, Truong PT, Berthelet E, Pai H, Joe H, Wai E, Larsson S, Kader HA, Weinerman B, Wilson K, Olivotto IA.

Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1328-35.

PMID:
14630270
9.

Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.

Wong SK, Chiu PW, Leung SF, Cheung KY, Chan AC, Au-Yeung AC, Griffith JF, Chung SS, Ng EK.

Ann Surg Oncol. 2008 Feb;15(2):576-82. Epub 2007 Dec 5.

PMID:
18057993
10.

Prognostic value of TP53 transcriptional activity on p21 and bax in patients with esophageal squamous cell carcinomas treated by definitive chemoradiotherapy.

Michel P, Magois K, Robert V, Chiron A, Lepessot F, Bodenant C, Roque I, Seng SK, Frebourg T, Paillot B.

Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):379-85.

PMID:
12243811
11.

Factors predictive of tumor recurrence and survival after initial complete response of esophageal squamous cell carcinoma to definitive chemoradiotherapy.

Ishihara R, Yamamoto S, Iishi H, Takeuchi Y, Sugimoto N, Higashino K, Uedo N, Tatsuta M, Yano M, Imai A, Nishiyama K.

Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):123-9. doi: 10.1016/j.ijrobp.2009.01.038.

PMID:
19386426
12.

Cervical nodal metastases of unresectable thoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after concurrent chemoradiotherapy.

Liu H, Lu L, Zhu Q, Hao Y, Mo Y, Liu M, Hu Y, Cui N, Rong T.

Radiother Oncol. 2011 May;99(2):181-6. doi: 10.1016/j.radonc.2011.05.011. Epub 2011 May 26.

PMID:
21620504
13.

Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer.

Tougeron D, Di Fiore F, Thureau S, Berbera N, Iwanicki-Caron I, Hamidou H, Paillot B, Michel P.

Br J Cancer. 2008 Nov 18;99(10):1586-92. doi: 10.1038/sj.bjc.6604749. Epub 2008 Oct 28.

14.

Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma.

He LR, Liu MZ, Li BK, Rao HL, Deng HX, Guan XY, Zeng YX, Xie D.

Cancer Sci. 2009 Sep;100(9):1591-6. doi: 10.1111/j.1349-7006.2009.01224.x. Epub 2009 May 18.

15.

Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer.

Borghesi S, Hawkins MA, Tait D.

Clin Oncol (R Coll Radiol). 2008 Apr;20(3):221-6. doi: 10.1016/j.clon.2007.12.001. Epub 2008 Jan 14.

PMID:
18248970
16.

Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer.

Di Fiore F, Lecleire S, Pop D, Rigal O, Hamidou H, Paillot B, Ducrotté P, Lerebours E, Michel P.

Am J Gastroenterol. 2007 Nov;102(11):2557-63. Epub 2006 Aug 4.

PMID:
17680847
17.

Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy.

Okumura H, Uchikado Y, Matsumoto M, Owaki T, Kita Y, Omoto I, Sasaki K, Sakurai T, Setoyama T, Nabeki B, Matsushita D, Ishigami S, Hiraki Y, Nakajo M, Natsugoe S.

Int J Clin Oncol. 2013 Apr;18(2):329-34. doi: 10.1007/s10147-012-0383-y. Epub 2012 Feb 18.

PMID:
22350023
18.

Efficacy of neoadjuvant chemoradiotherapy in resectable esophageal squamous cell carcinoma--a single institutional study.

Lee JL, Kim SB, Jung HY, Park SI, Kim DK, Kim JH, Song HY, Kim WK, Lee JS, Min YI.

Acta Oncol. 2003;42(3):207-17.

PMID:
12852697
19.

Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.

Shridhar R, Freilich J, Hoffe SE, Almhanna K, Fulp WJ, Yue B, Karl RC, Meredith K.

Ann Surg Oncol. 2014 Nov;21(12):3744-50. doi: 10.1245/s10434-014-3795-2. Epub 2014 May 23.

PMID:
24854492
20.

Definitive chemoradiotherapy in patients with esophageal adenocarcinoma: an alternative to surgery?

Tougeron D, Scotté M, Hamidou H, Di Fiore F, Paillot B, Michot F, Michel P.

J Surg Oncol. 2012 Jun 15;105(8):761-6. doi: 10.1002/jso.22157. Epub 2011 Nov 28.

PMID:
22124932

Supplemental Content

Support Center